RAPP — RAPPORT THERAPEUTICS INC

Ownership history in Maven Securities LTD  ·  2 quarters on record

This page tracks every 13F SEC filing in which Maven Securities LTD reported a position in RAPPORT THERAPEUTICS INC (RAPP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2025 Q3)
Avg. % of fund
0.01%
First filed
2024 Q3
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 20,000 -9,930 -33.2% 0.01% $594K $29.70
2024 Q3 INITIATED 29,930 — — 0.01% $613K $20.48
% of Fund (quarterly)    RAPP price (monthly, adj. close)

Other funds also holding RAPP

As of 2025 Q4 — sorted by position size

TRV GP V, LLC 50.44% TRV GP VI, LLC 19.8% ARCH Venture Management, LLC 3Y 7Y 17.36% JOHNSON & JOHNSON 3Y 9.76% Cormorant Asset Management, LP 3Y 7Y 4.25% Sofinnova Investments, Inc. 3Y 7Y 2.49% Vestal Point Capital, LP 1.14% SECTORAL ASSET MANAGEMENT INC 3Y 7Y 0.95% Sio Capital Management, LLC 3Y 7Y 0.88% Siren, L.L.C. 0.64%
← Back to Maven Securities LTD Holdings